Aberrant Effective Connectivity in Schizophrenia Patients during Appetitive Conditioning.
It has recently been suggested that schizophrenia involves dysfunction in brain connectivity at a neural level, and a dysfunction in reward processing at a behavioral level. The purpose of the present study was to link these two levels of analyses by examining effective connectivity patterns between brain regions mediating reward learning in patients with schizophrenia and healthy, age-matched controls. To this aim, we used functional magnetic resonance imaging and galvanic skin recordings (GSR) while patients and controls performed an appetitive conditioning experiment with visual cues as the conditioned (CS) stimuli, and monetary reward as the appetitive unconditioned stimulus (US). Based on explicit stimulus contingency ratings, conditioning occurred in both groups; however, based on implicit, physiological GSR measures, patients failed to show differences between CS+ and CS- conditions. Healthy controls exhibited increased blood-oxygen-level dependent (BOLD) activity across striatal, hippocampal, and prefrontal regions and increased effective connectivity from the ventral striatum to the orbitofrontal cortex (OFC BA 11) in the CS+ compared to the CS- condition. Compared to controls, patients showed increased BOLD activity across a similar network of brain regions, and increased effective connectivity from the striatum to hippocampus and prefrontal regions in the CS- compared to the CS+ condition. The findings of increased BOLD activity and effective connectivity in response to the CS- in patients with schizophrenia offer insight into the aberrant assignment of motivational salience to non-reinforced stimuli during conditioning that is thought to accompany schizophrenia.
Rotman Research Institute, Baycrest Centre Toronto, ON, Canada.
Andreea Oliviana
AO
Diaconescu
Jimmy
J
Jensen
Hongye
H
Wang
Matthäus
M
Willeit
Mahesh
M
Menon
Shitij
S
Kapur
Anthony R
AR
McIntosh
Hum Brain Mapp. 2006 Dec;27(12):935-47
16929548
Neuron. 2004 May 13;42(3):509-17
15134646
J Neurosci. 1995 Jul;15(7 Pt 1):4851-67
7623116
Front Hum Neurosci. 2009 Aug 17;3:17
19738925
Neuroimage. 1996 Jun;3(3 Pt 1):143-57
9345485
Neuroreport. 2005 Mar 15;16(4):355-9
15729137
Neuroimage. 2004;23 Suppl 1:S250-63
15501095
J Comp Neurol. 2000 Sep 25;425(3):447-70
10972944
Cereb Cortex. 1997 Dec;7(8):768-78
9408041
Neuron. 2003 Dec 18;40(6):1251-7
14687557
Magn Reson Med. 2004 Apr;51(4):863-8
15065263
Neuropsychopharmacology. 2010 Jan;35(1):4-26
19812543
Clin Neurosci. 1995;3(2):89-97
7583624
Mol Psychiatry. 2008 Mar;13(3):239, 267-76
17684497
Neuropsychopharmacology. 2003 Jul;28 Suppl 1:S35-9
12827142
Am J Psychiatry. 2007 Mar;164(3):450-7
17329470
J Neurosci. 2002 Dec 15;22(24):10829-37
12486176
Biol Psychiatry. 2000 Aug 1;48(3):204-9
10924663
Arch Gen Psychiatry. 2005 Apr;62(4):379-86
15809405
Neuroreport. 1998 Jun 1;9(8):1697-700
9665585
J Neurosci. 2007 May 2;27(18):4826-31
17475790
Neuropsychopharmacology. 2005 Dec;30(12):2283-9
16123775
Schizophr Bull. 2009 May;35(3):509-27
19155345
IEEE Trans Med Imaging. 2004 Feb;23(2):137-52
14964560
Schizophr Bull. 2007 Jul;33(4):1004-12
17556752
Am J Psychiatry. 2001 Nov;158(11):1809-17
11691686
Neuron. 2002 Feb 28;33(5):815-26
11879657
Psychiatry Res. 2007 Apr 15;154(3):221-32
17360163
Neuroimage. 2000 Apr;11(4):289-301
10725185
Schizophr Res. 2005 Oct 1;78(1):45-60
15979287
Neuroimage. 2003 Jul;19(3):751-63
12880804
Schizophr Res. 2005 Jan 1;72(2-3):215-24
15560966
Neuroimage. 2000 Jul;12(1):20-7
10875899
Hippocampus. 2001;11(5):599-613
11732711
Schizophr Res. 2007 May;92(1-3):74-84
17379482
Hum Brain Mapp. 2009 Nov;30(11):3795-811
19434601
Biol Psychiatry. 2009 Jun 15;65(12):1032-9
19195646
J Comp Neurol. 2002 Sep 2;450(4):345-65
12209848
Brain Res. 2010 Feb 8;1313:143-61
19961836
Neuroimage. 2003 Oct;20(2):1086-95
14568478
J Neurophysiol. 2000 Dec;84(6):3072-7
11110834
Psychopharmacology (Berl). 2008 Mar;196(4):673-84
18097655
Neurosci Lett. 2007 May 7;417(3):297-302
17399900
Comput Biomed Res. 1996 Jun;29(3):162-73
8812068
Psychol Med. 2001 Aug;31(6):1065-78
11513374
Psychiatry Res. 2007 Aug 30;152(2-3):113-20
17462743
Biol Psychiatry. 2003 Apr 1;53(7):601-8
12679238
Brain. 2005 Nov;128(Pt 11):2597-611
16183659
Neuropsychopharmacology. 2008 Feb;33(3):473-9
17473838
J Neurosci. 2001 Aug 15;21(16):RC159
11459880
Biol Psychiatry. 2002 Jun 15;51(12):1008-11
12062886
J Neurosci. 2004 Apr 28;24(17):4105-12
15115805
Neuropsychologia. 2008;46(7):2002-12
18329673
Psychopharmacology (Berl). 2004 Oct;175(4):473-80
15083259
Psychiatry Res. 2007 Aug 30;152(2-3):121-8
17507100
Memory. 1999 Sep-Nov;7(5-6):523-48
10659085
Psychopharmacology (Berl). 2006 Aug;187(2):222-8
16721614
Schizophr Res. 2001 Sep 1;51(2-3):127-36
11518633
Hum Brain Mapp. 2007 Nov;28(11):1213-22
17266108